PATRICIA BOYD: Open Payments
NPI 1306547179 · ROCKY MOUNT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$322 in 16 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $642 · 2025 $322
Food & beverage: $322
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $45 |
| Novo Nordisk Inc | 2 | $43 |
| ABBVIE INC. | 2 | $38 |
| GlaxoSmithKline, LLC. | 1 | $34 |
| Amgen Inc. | 2 | $29 |
| SANOFI PASTEUR INC. | 1 | $26 |
| Corcept Therapeutics | 1 | $25 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Kerendia, XIFAXAN, TRELEGY ELLIPTA, OTEZLA, VAXELIS, Korlym, VRAYLAR, Wegovy.
Industry payments across NC — which companies pay providers there.
